Return to Statistics Toolbox

Volcano Plot analysis for Study ST003786

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:288 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:489 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:619 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:- (1)
Sample source:Human stool ex vivo culture | Stool Donor:745 | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:- (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:1 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:- (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:1 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:- (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:2 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:- (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:2 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:- (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:3 | Time_point:0h | Treatment:Maslinic acid (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:- (1)
Sample source:Media used for stool cultures | Stool Donor:None | QCRole:Sample | Replicate:3 | Time_point:48h | Treatment:Maslinic acid (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-drift_correction | Replicate:PREFA01 | Time_point:PREFA01 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-drift_correction | Replicate:PREFA02 | Time_point:PREFA02 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-drift_correction | Replicate:PREFA03 | Time_point:PREFA03 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-drift_correction | Replicate:PREFA04 | Time_point:PREFA04 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-pooled_ref | Replicate:PREFB01 | Time_point:PREFB01 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-pooled_ref | Replicate:PREFB02 | Time_point:PREFB02 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-pooled_ref | Replicate:PREFB03 | Time_point:PREFB03 | Treatment:- (1)
Sample source:Quality control pool | Stool Donor:- | QCRole:QC-pooled_ref | Replicate:PREFB04 | Time_point:PREFB04 | Treatment:- (1)
Sample source:Titration of Quality control pool | Stool Donor:- | QCRole:Titration | Replicate:Titration-100 | Time_point:Titration-100 | Treatment:- (1)
Sample source:Titration of Quality control pool | Stool Donor:- | QCRole:Titration | Replicate:Titration-10 | Time_point:Titration-10 | Treatment:- (1)
Sample source:Titration of Quality control pool | Stool Donor:- | QCRole:Titration | Replicate:Titration-20 | Time_point:Titration-20 | Treatment:- (1)
Sample source:Titration of Quality control pool | Stool Donor:- | QCRole:Titration | Replicate:Titration-40 | Time_point:Titration-40 | Treatment:- (1)
Sample source:Titration of Quality control pool | Stool Donor:- | QCRole:Titration | Replicate:Titration-60 | Time_point:Titration-60 | Treatment:- (1)
Sample source:Titration of Quality control pool | Stool Donor:- | QCRole:Titration | Replicate:Titration-80 | Time_point:Titration-80 | Treatment:- (1)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo